- Home
- Archives
- 2026
- Vol. 1 Issue 3
- Article
Oral Antidiabetic-Induced Hypoglycaemia with Unrecognised Renal Impairment in Newly Diagnosed Type 2 Diabetes Mellitus: A Case Report
Authors
1 2 3 4 5 Department of Pharmacy Practice, BVV Sangha’s Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote, Karnataka, India.
Article Information
- DOI
- No Doi
- Published In
- Year 2026 · Volume 1 · Issue 3
- Published Online
- September-December 2026
- Pages
- 18-24
- Article Type
- Case Report
- Check for updates
-
Abstract
View PDFHypoglycaemia is the factor that most often limits glycaemic management in type 2 diabetes mellitus, and in the majority of instances it arises from treatment rather than from disease. We describe a 60-year-old man whose diabetes had been diagnosed only two to three months earlier and who was maintained on voglibose together with a fixed-dose combination of glimepiride and metformin. He presented with two days of altered sensation and loss of consciousness, which had resolved after he ate a chocolate. At admission he was conscious and oriented, with blood pressure 110/70 mmHg and pulse rate 86 beats per minute. Investigation showed haemoglobin 9.6 g/dL, fasting blood glucose 107 mg/dL, blood urea 47.1 mg/dL and serum creatinine 1.7 mg/dL, corresponding to an estimated glomerular filtration rate of approximately 46 mL/min/1.73 m² by the 2021 CKD-EPI creatinine equation. No assessment of renal function from the period preceding the prescription was available. All oral antidiabetic agents were withdrawn and therapy was converted to subcutaneous regular human insulin, with intravenous ceftriaxone and oral nitrofurantoin for a urinary tract infection, alongside supportive agents. Capillary glucose nevertheless fell to 50 mg/dL and 56 mg/dL during the admission. The patient was discharged after five days with a final diagnosis of type 2 diabetes mellitus with urinary tract infection. Structured review of the medication record identified eight drug-related problems, the most consequential being initiation of a renally eliminated insulin secretagogue without baseline renal assessment, prescription of nitrofurantoin at a filtration rate immediately above its contraindication threshold in a patient with concurrent anaemia, diabetes and sensory symptoms, administration of a single fixed daily insulin dose, and an ambiguous discharge instruction expressed as concentration rather than units. Every one of these was identifiable from data already present in the record. The case demonstrates that renal function must govern both antidiabetic and antimicrobial selection, and defines the contribution of structured clinical pharmacist review.
Related Articles in this Issue
Share Article
*Instagram doesn't support direct link sharing from web. Copy the link and share it in your Instagram story or post.